Xi-Shan Wang
Overview
Explore the profile of Xi-Shan Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Han C, Zhuang M, Zhao W, Hu G, Qiu W, et al.
World J Gastrointest Surg
. 2025 Jan;
17(1):98263.
PMID: 39872770
Background: Endoscopy allows for the direct observation of primary tumor characteristics and responses after neoadjuvant treatment. However, reports on endoscopic evaluation following neoadjuvant immunotherapy remain limited. Aim: To examine the...
2.
Liu W, Tang Y, Li N, Tang Y, Cheng Y, Yang L, et al.
BMC Geriatr
. 2024 May;
24(1):442.
PMID: 38773457
Background: The purpose of this study was to evaluate the safety and efficacy of preoperative concurrent chemoradiotherapy (preCRT) for locally advanced rectal cancer in older people who were classified as...
3.
Quan J, Zhou X, Mei S, Liu J, Qiu W, Zhang J, et al.
World J Gastrointest Surg
. 2023 Oct;
15(9):1969-1977.
PMID: 37901737
Background: It remains unclear whether laparoscopic multisegmental resection and anastomosis (LMRA) is safe and advantageous over traditional open multisegmental resection and anastomosis (OMRA) for treating synchronous colorectal cancer (SCRC) located...
4.
Liu J, Yang M, Bai J, Liu Z, Wang X
World J Gastrointest Oncol
. 2023 Mar;
15(2):240-250.
PMID: 36908324
The advent of immunotherapy and the development of immune checkpoint inhibitors (ICIs) are changing the way we think about cancer treatment. ICIs have shown clinical benefits in a variety of...
5.
Liu W, Shi J, Li N, Wang X, Gao Y, Chi Y, et al.
Radiat Oncol
. 2022 Dec;
17(1):214.
PMID: 36578032
Purpose: The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy (SCPRT) for unresectable rectal cancer is assessed with a planned interim analysis. Methods And Materials: Patients diagnosed with...
6.
Jin J, Tang Y, Hu C, Jiang L, Jiang J, Li N, et al.
J Clin Oncol
. 2022 Mar;
40(15):1681-1692.
PMID: 35263150
Purpose: To ascertain if preoperative short-term radiotherapy followed by chemotherapy is not inferior to a standard schedule of long-term chemoradiotherapy in patients with locally advanced rectal cancer. Materials And Methods:...
7.
Wang L, Zou S, Dong L, Yang M, Qi D, Lu Z, et al.
Gastroenterol Rep (Oxf)
. 2021 Dec;
9(6):552-559.
PMID: 34925852
Background: Lynch-syndrome-associated cancer is caused by germline pathogenic mutations in mismatch repair genes. The major challenge to Lynch-syndrome screening is the interpretation of variants found by diagnostic testing. This study...
8.
Sun P, Quan J, Wang S, Zhuang M, Liu Z, Guan X, et al.
Gastroenterol Rep (Oxf)
. 2021 Jul;
9(3):257-268.
PMID: 34316376
Background: p50-associated cyclooxygenase-2 extragenic RNA (PACER) is a recently identified antisense long non-coding RNA (lncRNA) located on the upstream of the promoter region of cyclooxygenase-2 (). Preliminary studies have suggested...
9.
Qiao T, Yuan Z, Ma T, Hu H, Zhu Y, Zhang W, et al.
Neoplasma
. 2021 Jun;
68(5):947-954.
PMID: 34156255
Colorectal cancer is the third leading cancer in the world in terms of incidence and mortality. The role of differentially expressed Claudin-14 (CLDN14) in CRC has not been reported. We...
10.
Zhou S, Pei W, Sun Z, Zhou Z, Wang X, Liang J, et al.
Chin Med J (Engl)
. 2021 Jun;
134(12):1505-1507.
PMID: 34134126
No abstract available.